Skip to main navigation Skip to search Skip to main content

Activity of Eravacycline Against Carbapenem-resistant Enterobacteriaceae

Grants and Contracts Details

StatusFinished
Effective start/end date11/26/18 → 6/30/20

Funding

  • Tetraphase Pharmaceuticals Incorporated: $13,020.00